When red blood cells break down, they release heme, a component of hemoglobin that can contribute to inflammation and damage ...

The FDA approval marks another successful step in J&J’s aim of achieving $5bn in peak sales for the drug.

(Fixes broken link in final paragraph) By Kunal Das and Padmanabhan Ananthan Aug 24 (Reuters) - The U.S. Food and Drug ...

Takeda Pharmaceutical’s Mimrylo is now approved for treating polycythemia vera, a rare blood cancer with limited therapeutic ...

A single one-time gene therapy could free patients with α-thalassemia, a rare and debilitating blood disorder, from the burden of lifelong transfusions. A single one-time gene therapy could free ...

Nadia D. Ali, MD, is eager to attend the upcoming 2024 ASH Annual Meeting and Exposition, particularly for sessions on nonmalignant hematology, focusing on red blood cells, erythropoiesis, and ...

Conference MDAngle offers personal perspectives from conference attendees, showcasing their anticipation, quick takeaways, and insights into how the presented research will affect their patients. The ...

Patients with sickle cell disease are often hesitant to undergo transformative gene therapy—the current lengthy process ...

Vascarta Inc., a clinical-stage biopharmaceutical company advancing transdermal curcuminoid therapeutics for pain, inflammation, and sickle cell disease (SCD), today outlined a proposed mechanistic ...

Blood disorders affect millions of people worldwide, yet their potential to develop into blood cancers often goes unrecognized. Medical experts emphasize that understanding this connection plays a ...